Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Spondyloarthritis family · A closer look at PsA

PsA: family planning, pregnancy and breastfeeding

Planning a family involves more than a list of permitted medicines. Make room for disease control, fertility, feeding choices and the practical demands of caring for a baby.

Olga Goodman, MD · Sources checked 27 September 2026

Chapter 13 of 21

The essentials

Discuss pregnancy plans before changing contraception or treatment. Advice for the person carrying a pregnancy and for a prospective father can differ. Agree a plan for pregnancy and the months after birth with your care team.

Start the conversation before conception

Bring your complete medicine list, including skin treatments, pain medicines and supplements. Explain whether you want to conceive soon, later, or are unsure. A useful question is: what needs to be in place before we start trying?

Preconception care aims for well-controlled disease on suitable treatment. Stopping effective treatment without a replacement can leave inflammation uncontrolled. The rheumatology and obstetric teams should share the same plan. 1, 2

Ask about each medicine, not just its class

Methotrexate must not be used during pregnancy; it requires a planned change before conception. Leflunomide also needs a specific preconception plan, sometimes including supervised accelerated elimination. The interval depends on the medicine, the current product information and your circumstances. 1, 2

Biologic treatment is not automatically incompatible with pregnancy. The 2024 EULAR update allows TNF inhibitors throughout pregnancy after individual assessment; other agents require their own evidence review. Do not replace a successful drug simply because another has a more reassuring name. 1

If pregnancy is possible or a test is positive while taking a medicine that may be unsuitable, contact the prescriber promptly, especially before another dose of methotrexate. Record the drug, dose and dates. Exposure alone does not establish that harm has occurred.

Questions for prospective fathers

A paternal exposure is not the same as taking a medicine during pregnancy. Do not apply the mother's stop list to the father. Review the exact drug and current guidance together, including any difference between the product label and specialist recommendations. 1, 2

Difficulty conceiving deserves assessment of both partners. Sulfasalazine can reversibly affect sperm count or quality; discuss this if conception is delayed. It is a reason for a focused review, not an instruction to abandon effective treatment. 2

During pregnancy: keep the plan connected

Tell each team who coordinates prescriptions and blood tests, and how to report a flare. Joint symptoms, skin disease, fatigue and mechanical discomfort may need different explanations. Do not assume that pregnancy will make PsA disappear.

Tell the baby's future clinician which biologic was used and when. Exposure during pregnancy may matter for some live vaccines; timing is drug-specific and should be agreed with the paediatric team. Do not postpone every infant vaccination on your own. 1, 9

After birth and during breastfeeding

Arrange a follow-up date and an agreed flare plan before delivery. Think about lifting the baby, feeding positions, hand pain, sleep and help at home. Make the plan usable on a difficult day: who can collect medicines, arrange a test or contact the team?

Many treatments can be used while breastfeeding, but the assessment differs from pregnancy. Check the exact medicine, dose and the baby's circumstances, including prematurity. A recommendation to avoid a drug because data are limited is not proof that it causes harm. 1, 2

Your feeding preferences belong in the discussion. If advice conflicts, ask the rheumatologist, obstetric clinician and paediatrician to reconcile it rather than leaving you to choose between contradictory instructions.

RV-PSA-05 · Branches of the Family Tree — Free after registration →

Leave with a written family plan

Use these headings at the next visit. Fill them with your clinicians rather than treating a general table as a prescription.

Leave with a written family plan
DecisionWhat to record
Before tryingCurrent disease control; medicines to continue or change; contraception until the agreed point; who confirms readiness.
During pregnancyContact for a flare; monitoring; coordination with obstetrics; any delivery-related treatment plan.
After birthFollow-up date; feeding-compatible plan; practical help; information for the baby's clinician.

Pregnancy and family planning — Free after registration →

Go deeper

Why recommendations and medicine leaflets may differ

Pregnant people are usually excluded from drug trials. Much safety evidence therefore comes from pregnancy registries and observational studies. These can be reassuring without proving zero risk. Timing, dose, disease activity and reasons for choosing treatment also affect interpretation. 1, 2

A guideline weighs this evidence against the risks of uncontrolled disease. A product label may take a more cautious position or change at a different pace. Ask which source applies to your exact drug and country, what uncertainty remains and what alternative preserves disease control. The EULAR update is labelled 2024 and was published in 2025; the ACR guideline cited here is from 2020.

Questions for your visit

  1. Is my disease controlled enough to start trying, and what still needs review?
  2. What is the plan for each medicine for the person carrying the pregnancy and for the prospective father?
  3. Who should I contact if pregnancy happens earlier than planned?
  4. What will we do about a flare, breastfeeding and infant vaccinations after birth?

When to seek urgent help

A painful red eye, light sensitivity or a sudden change in vision needs urgent assessment. A newly hot, swollen joint, especially with fever or feeling unwell, also needs prompt assessment.

Sources & evidence notes

Sources checked 27 September 2026

The dates identify the versions used. General guidance needs an individual decision; drug labels, age-specific indications and local vaccination schedules also matter.

  1. Rüegg L et al. EULAR antirheumatic drugs in reproduction, pregnancy and lactation: 2024 update. Ann Rheum Dis. 2025.
  2. Sammaritano LR et al. ACR reproductive health guideline. Arthritis Rheumatol. 2020.
  3. Bass AR et al. ACR guideline for vaccinations in rheumatic and musculoskeletal diseases. 2022 guideline. Arthritis Rheumatol. 2023.

Educational information for patients and caregivers. This personal publication is not the clinic portal and does not provide individual diagnosis or treatment. Discuss medication changes with your own care team.

© 2026 Olga Goodman, MD · A RheumaView publication. Copying without attribution prohibited.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Care coordinationPregnancyPsoriasisPsoriatic arthritisSpondyloarthritis